FOLH1 and prostate carcinoma: To obtain prostate cancer-related exosomes, immunomagnetic beads coated with an anti-prostate-specific membrane antigen (PSMA) antibody can be applied to isolate them from the plasma of prostate cancer patients (Mizutani et al., 2014).